|
Volumn 4, Issue 2, 2016, Pages e94-e95
|
Xpert MTB/RIF for tuberculosis testing: Access and price in highly privatised health markets
b
FIND
(Switzerland)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COST CONTROL;
ECONOMIC ASPECT;
HEALTH CARE ACCESS;
HEALTH PROGRAM;
HUMAN;
LETTER;
LIQUID CULTURE;
MARKET;
PRIORITY JOURNAL;
QUALITY CONTROL;
TUBERCULIN TEST;
TUBERCULOSIS;
COMMERCIAL PHENOMENA;
ECONOMICS;
GENETICS;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
MOLECULAR DIAGNOSIS;
MYCOBACTERIUM TUBERCULOSIS;
PRIVATE SECTOR;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
BACTERIAL DNA;
RIFAMPICIN;
COMMERCE;
DNA, BACTERIAL;
HEALTH CARE COSTS;
HEALTH CARE SECTOR;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MYCOBACTERIUM TUBERCULOSIS;
PRIVATE SECTOR;
RIFAMPIN;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
EID: 84957606847
PISSN: None
EISSN: 2214109X
Source Type: Journal
DOI: 10.1016/S2214-109X(15)00269-7 Document Type: Letter |
Times cited : (24)
|
References (7)
|